news
At Pulmatrix, we are committed to communicating clear and consistent information. Here we feature current and historic content concerning our science, our pipeline,
and our corporate initiatives and achievements. Please check in often for the most recent press releases and information.
Press Releases: 11/02/09
Pulmatrix Closes $30.2 Million in Series B Financing
11/02/09
Pulmatrix Receives $2.2 Million from NIH/NIAID to Develop Novel Inhaled Influenza Therapeutics
05/01/09
Pulmatrix Announces Ph 1b/2a Clinical Trial of Novel iCALM Therapy for Flu
Press Releases: 11/02/09
Pulmatrix Closes $30.2 Million in Series B Financing
11/02/09
Pulmatrix Receives $2.2 Million from NIH/NIAID to Develop Novel Inhaled Influenza Therapeutics
05/01/09
Pulmatrix Announces Ph 1b/2a Clinical Trial of Novel iCALM Therapy for Flu